Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use
- PMID: 16472562
- DOI: 10.1016/j.contraception.2005.09.009
Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use
Abstract
Objectives: The purpose of this study was to characterize ovarian follicular and endometrial development during conventional vs. continuous oral contraceptive (OC) dosing regimens, to explore follicular development during the hormone-free interval (HFI) and to examine follicular development following OC discontinuation.
Study methods: A randomized clinical trial involving 36 clinically normal healthy women between the ages of 18 and 35 years (24.4 +/- 3.9, SEM). Transvaginal ultrasonography and blood sampling were done to ascertain ovarian function.
Results: Fewer follicles > 4 mm developed during continuous vs. conventional OC use (p = .006). No dominant follicles developed during continuous OC use vs. eight dominant follicles (16.1 +/- 3.3 mm) during the conventional OC regimen. Two of eight (25%) dominant follicles ovulated. All dominant follicles began development during the HFI. Following discontinuation of OC use, ovulation took approximately 5 days longer when compared to natural cycles.
Conclusion: Continuous OC regimens more effectively prevent dominant follicle development and breakthrough ovulation. The slight delay in time to ovulation following OC discontinuation and natural cycles could be attributed to suppression of follicle wave activity.
Similar articles
-
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.Contraception. 2004 Nov;70(5):371-7. doi: 10.1016/j.contraception.2004.05.006. Contraception. 2004. PMID: 15504375 Clinical Trial.
-
Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens.Contraception. 2008 Mar;77(3):162-70. doi: 10.1016/j.contraception.2007.11.005. Epub 2008 Jan 11. Contraception. 2008. PMID: 18279685 Clinical Trial.
-
Predicting risk of ovulation in new start oral contraceptive users.Obstet Gynecol. 2002 Feb;99(2):177-82. doi: 10.1016/s0029-7844(01)01676-3. Obstet Gynecol. 2002. PMID: 11814492 Clinical Trial.
-
Ovarian follicular development during the use of oral contraception: a review.J Obstet Gynaecol Can. 2004 Jan;26(1):19-24. doi: 10.1016/s1701-2163(16)30692-2. J Obstet Gynaecol Can. 2004. PMID: 14715122 Free PMC article. Review.
-
Rationale for eliminating the hormone-free interval in modern oral contraceptives.Int J Gynaecol Obstet. 2016 Jul;134(1):8-12. doi: 10.1016/j.ijgo.2015.10.028. Epub 2016 Mar 20. Int J Gynaecol Obstet. 2016. PMID: 27067074 Review.
Cited by
-
Characteristics of the menstrual cycle after discontinuation of oral contraceptives.J Womens Health (Larchmt). 2011 Feb;20(2):169-77. doi: 10.1089/jwh.2010.2001. Epub 2011 Jan 10. J Womens Health (Larchmt). 2011. PMID: 21219248 Free PMC article.
-
Consensus Statement on the Use of Oral Contraceptive Pills in Polycystic Ovarian Syndrome Women in India.J Hum Reprod Sci. 2018 Apr-Jun;11(2):96-118. doi: 10.4103/jhrs.JHRS_72_18. J Hum Reprod Sci. 2018. PMID: 30158805 Free PMC article.
-
ZMapp reduces diffusion of Ebola viral particles in fresh human cervicovaginal mucus.Emerg Microbes Infect. 2024 Dec;13(1):2352520. doi: 10.1080/22221751.2024.2352520. Epub 2024 May 16. Emerg Microbes Infect. 2024. PMID: 38713593 Free PMC article.
-
Offering extended use of the combined contraceptive pill: a survey of specialist family planning services.Int J Womens Health. 2013 Sep 30;5:613-7. doi: 10.2147/IJWH.S51329. eCollection 2013. Int J Womens Health. 2013. PMID: 24109198 Free PMC article.
-
Clinical and sonographic impact of oral contraception in patients with deep endometriosis and adenomyosis at 2 years of follow-up.Sci Rep. 2023 Feb 4;13(1):2066. doi: 10.1038/s41598-023-29227-2. Sci Rep. 2023. PMID: 36739298 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources